Iovance Biotherapeutics, Inc.

Historical 13F Holders

Symbol
IOVA
CUSIP
462260100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 462260100 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 7.5% 7/28/2026
Event 6/30/2026
State Street Corp 13G 5.5% 8/7/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Perceptive Advisors LLC 13G/A
3.8% 5/15/2025
Event 3/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 5 1.12 M $16.6 M
2026 Q2 309 288 M $1.59 B
2026 Q1 306 269 M $944 M
2025 Q4 281 262 M $716 M
2025 Q3 269 214 M $465 M
2025 Q2 265 223 M $383 M
2025 Q1 319 240 M $799 M
2024 Q4 328 242 M $1.79 B
2024 Q3 307 237 M $2.23 B
2024 Q2 318 239 M $1.92 B
2024 Q1 309 227 M $3.36 B
2023 Q4 260 218 M $1.77 B
2023 Q3 258 214 M $972 M
2023 Q2 238 204 M $1.44 B
2023 Q1 245 206 M $1.26 B
2022 Q4 233 188 M $1.20 B
2022 Q3 260 154 M $1.48 B
2022 Q2 260 161 M $1.76 B
2022 Q1 270 156 M $2.60 B
2021 Q4 279 167 M $3.17 B
2021 Q3 272 158 M $3.88 B
2021 Q2 267 173 M $4.50 B
2021 Q1 280 166 M $5.26 B
2020 Q4 299 149 M $6.91 B
2020 Q3 275 140 M $4.61 B
2020 Q2 286 141 M $3.88 B
2020 Q1 254 126 M $3.76 B
2019 Q4 226 126 M $3.48 B
2019 Q3 186 124 M $2.25 B
2019 Q2 188 123 M $3.00 B
2019 Q1 160 118 M $1.12 B
2018 Q4 145 120 M $1.06 B
2018 Q3 141 91.9 M $1.03 B
2018 Q2 134 83.4 M $1.07 B
2018 Q1 133 77.9 M $1.32 B
2017 Q4 96 57.6 M $461 M
2017 Q3 93 55.3 M $429 M
2017 Q2 89 47.6 M $349 M